Literature DB >> 34272253

Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'.

Timm H Westhoff1, Felix S Seibert1, Moritz Anft2,3, Arturo Blazquez-Navarro2,3,4, Sarah Skrzypczyk2,3, Adrian Doevelaar1, Bodo Hölzer1, Krystallenia Paniskaki5, Sebastian Dolff5, Benjamin Wilde6, Oliver Witzke6, Juergen Braun7, Ulrik Stervbo2,3,4, Nina Babel8,3,4.   

Abstract

Entities:  

Keywords:  Covid-19; rituximab; vaccination

Year:  2021        PMID： 34272253     DOI： 10.1136/annrheumdis-2021-220756

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  [Are SARS-CoV-2 reactive T cells detectable and potentially protective in patients under anti-CD20 treatment with an impaired humoral response?]

Authors:  J Braun; T Westhoff; X Baraliakos; N Babel
Journal:  Z Rheumatol       Date:  2021-09-16       Impact factor: 1.530

2.  COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis.

Authors:  Yusuke Ito; Akira Honda; Mineo Kurokawa
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2022-03-28

3.  SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry.

Authors:  Jean Liew; Milena Gianfrancesco; Carly Harrison; Zara Izadi; Stephanie Rush; Saskia Lawson-Tovey; Lindsay Jacobsohn; Clairissa Ja; Kimme L Hyrich; Laure Gossec; Anja Strangfeld; Loreto Carmona; Martin Schäfer; Elsa Frãzao-Mateus; Inita Bulina; Frances Stafford; Abdurrahman Tufan; Christine Graver; Gözde Kübra Yardımcı; Julija Zepa; Samar Al Emadi; Claire Cook; Fatemah Abutiban; Dfiza Dey; Genevieve Katigbak; Lauren Kaufman; Emily Kowalski; Marco Ulises Martínez-Martínez; Naomi J Patel; Greta Reyes-Cordero; Evelyn Salido; Ellison Smith; David Snow; Jeffrey Sparks; Leanna Wise; Suleman Bhana; Monique Gore-Massy; Rebecca Grainger; Jonathan Hausmann; Emily Sirotich; Paul Sufka; Zachary Wallace; Pedro M Machado; Philip C Robinson; Jinoos Yazdany
Journal:  RMD Open       Date:  2022-04

4.  Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2.

Authors:  Nina Babel; Timm H Westhoff; Sebastian Bertram; Arturo Blazquez-Navarro; Maximilian Seidel; Bodo Hölzer; Felix S Seibert; Adrian Doevelaar; Benjamin Rohn; Panagiota Zgoura; Alexandra Witte-Lack; Sarah Skrzypczyk; David Scholten; Klaus Kisters
Journal:  Sci Rep       Date:  2022-04-14       Impact factor: 4.379

5.  B Cell Numbers Predict Humoral and Cellular Response Upon SARS-CoV-2 Vaccination Among Patients Treated With Rituximab.

Authors:  Ana-Luisa Stefanski; Hector Rincon-Arevalo; Eva Schrezenmeier; Kirsten Karberg; Franziska Szelinski; Jacob Ritter; Bernd Jahrsdörfer; Hubert Schrezenmeier; Carolin Ludwig; Arne Sattler; Katja Kotsch; Yidan Chen; Anne Claußnitzer; Hildrun Haibel; Fabian Proft; Gabriela Guerra; Pawel Durek; Frederik Heinrich; Marta Ferreira-Gomes; Gerd R Burmester; Andreas Radbruch; Mir-Farzin Mashreghi; Andreia C Lino; Thomas Dörner
Journal:  Arthritis Rheumatol       Date:  2022-04-17       Impact factor: 15.483

6.  Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination.

Authors:  Ioana Andreica; Arturo Blazquez-Navarro; Jan Sokolar; Moritz Anft; Uta Kiltz; Stephanie Pfaender; Elena Vidal Blanco; Timm Westhoff; Nina Babel; Ulrik Stervbo; Xenofon Baraliakos
Journal:  RMD Open       Date:  2022-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.